Denufosol for cystic fibrosis with mild lung disease
HTA - Health Technology Assessment Report
Details- 2009
- National Horizon Scanning Centre
Colistimethate sodium powder for inhalation (Colobreathe) for pseudomonas aeruginosa lung infection in cystic fibrosis
HTA - Health Technology Assessment Report
Details- 2009
- National Horizon Scanning Centre
- 2009
- Purins A, Hiller JE
An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis.
NHSEED - Economic Study or Review
Details- 2017
- Tappenden P
Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data
NHSEED - Economic Study or Review
Details- 2014
- van der Ploeg CP
Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients
NHSEED - Economic Study or Review
Details- 2013
- Cies JJ
Cost effectiveness of newborn screening for cystic fibrosis: a simulation study
NHSEED - Economic Study or Review
Details- 2013
- Nshimyumukiza L
The cost effectiveness of dry powder antibiotics for the treatment of pseudomonas aeruginosa in patients with cystic fibrosis (Provisional abstract)
NHSEED - Economic Study or Review
Details- 2013
- Tappenden P
Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
NHSEED - Economic Study or Review
Details- 2012
- Norman R
Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis
NHSEED - Economic Study or Review
Details- 2012
- Urquhart D